source
- Endpoints 11 showcases top biotech startups, signaling renewed optimism and fundingThe Endpoints 11 awards highlight the most promising biotech startups of 2026, offering a snapshot of emerging trends in the sector. According to the summary, the awards illustrate that biotech ap…
- Indivior ends Addex PAM collaboration as it prepares for Supernus mergerIndivior Pharmaceuticals has terminated its long‑standing partnership with Addex Therapeutics that focused on developing positive allosteric modulators (PAMs) for addiction treatment. The collabor…